Stable overexpression of protein tyrosine phosphatases: effect on insulin signalling.
Orr
S R
SR
Cancer, Metabolism and Endocrinology Department, ZENECA Pharmaceuticals, Macclesfield, Cheshire.
Holloway
B R
BR
D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D007328:Insulin / Q000494:pharmacology*; D019000:Phosphotyrosine / Q000032:analysis; D017027:Protein Tyrosine Phosphatases / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000096:biosynthesis; D011972:Receptor, Insulin / Q000378:metabolism / Q000502:physiology*; D054630:Receptor-Like Protein Tyrosine Phosphatases, Class 4; D011956:Receptors, Cell Surface; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology; D014162:Transfection
D007328:Insulin; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D011994:Recombinant Proteins; D019000:Phosphotyrosine; D011972:Receptor, Insulin; D017027:Protein Tyrosine Phosphatases; D054630:Receptor-Like Protein Tyrosine Phosphatases, Class 4